Literature DB >> 23474961

Imaging of Ménière's disease after intravenous administration of single-dose gadodiamide: utility of multiplication of MR cisternography and HYDROPS image.

Shinji Naganawa1, Masahiro Yamazaki, Hisashi Kawai, Kiminori Bokura, Michihiko Sone, Tsutomu Nakashima.   

Abstract

A HYDROPS (HYbriD of Reversed image Of Positive endolymph signal and native image of positive perilymph Signal) image, created by subtracting a positive endolymph image from a positive perilymph image after intravenous injection of single-dose gadodiamide, has been reported to facilitate recognition of endolymphatic hydrops. To further increase the contrast-to-noise ratio (CNR) of HYDROPS images, we multiplied a T2-weighted MR cisternographic image onto the HYDROPS image. Ten patients with suspected Ménière's disease were included. The average CNR of generated images increased to more than 200 times that of HYDROP images.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474961     DOI: 10.2463/mrms.2012-0027

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  16 in total

Review 1.  Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance.

Authors:  Shinji Naganawa; Tsutomu Nakashima
Journal:  Jpn J Radiol       Date:  2014-02-06       Impact factor: 2.374

2.  Recurrent peripheral vestibulopathy: Is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice?

Authors:  Arnaud Attyé; G Dumas; I Troprès; M Roustit; A Karkas; E Banciu; J Pietras; L Lamalle; S Schmerber; A Krainik
Journal:  Eur Radiol       Date:  2015-03-28       Impact factor: 5.315

3.  Assessment of the Progression of Vertical Semicircular Canal Dysfunction and Increased Vestibular Endolymphatic Hydrops in Patients With Early-Stage Ménière Disease.

Authors:  Munehisa Fukushima; Yuya Ueno; Itsuki Kitayama; Shiro Akahani; Hidenori Inohara; Noriaki Takeda
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-09-01       Impact factor: 6.223

Review 4.  Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

Authors:  Rita Sousa; Francisco Raposo; Carla Guerreiro; David Berhanu; Tiago Eça; J Campos; Leonel Luís
Journal:  Neuroradiology       Date:  2021-06-17       Impact factor: 2.804

5.  Intravenous Delayed Gadolinium-Enhanced MR Imaging of the Endolymphatic Space: A Methodological Comparative Study.

Authors:  Rainer Boegle; Johannes Gerb; Emilie Kierig; Sandra Becker-Bense; Birgit Ertl-Wagner; Marianne Dieterich; Valerie Kirsch
Journal:  Front Neurol       Date:  2021-04-22       Impact factor: 4.003

6.  Reappraisal of the glycerol test in patients with suspected Menière's disease.

Authors:  Bernd Lütkenhöner; Türker Basel
Journal:  BMC Ear Nose Throat Disord       Date:  2014-11-24

Review 7.  What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.

Authors:  R Gürkov; I Pyykö; J Zou; E Kentala
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

8.  Longitudinal up-regulation of endolymphatic hydrops in patients with Meniere's disease during medical treatment.

Authors:  Munehisa Fukushima; Tadashi Kitahara; Ryohei Oya; Shiro Akahani; Hidenori Inohara; Shinji Naganawa; Noriaki Takeda
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-10-31

9.  Heavily T₂-Weighted 3D-FLAIR Improves the Detection of Cochlear Lymph Fluid Signal Abnormalities in Patients with Sudden Sensorineural Hearing Loss.

Authors:  Shinji Naganawa; Hisashi Kawai; Toshiaki Taoka; Kojiro Suzuki; Shingo Iwano; Hiroko Satake; Michihiko Sone; Mitsuru Ikeda
Journal:  Magn Reson Med Sci       Date:  2015-11-20       Impact factor: 2.471

10.  Morphological correlation between caloric tests and vestibular hydrops in Ménière's disease using intravenous Gd enhanced inner ear MRI.

Authors:  Ji Eun Choi; Yi-Kyung Kim; Young Sang Cho; Kieun Lee; Hyun Woo Park; Sung Hoon Yoon; Hyung-Jin Kim; Won-Ho Chung
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.